Information Library
Case Studies - Specialty Care
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Outsourced commercial strategy for multi-market launch
August 13, 2009
This study looks at how a UK-based biotech company managed a 12-country launch by outsourcing its requirement for a top performing specialty sales force. Not only did they prove it could be done, but the launch was also achieved in record time and has continued to beat its KPIs. -
Blockbuster reaches 7 new markets in record time
August 13, 2009
This study looks at a fully paid up member of ‘Big Pharma’ and its preparation for the international launch of one of its blockbuster drugs. It examines how outsourcing enabled them to get to market in time and then quickly out-perform the competition. -
Outsourcing for Pan-European launch success
August 13, 2009
This study is about research company PharmaMar and the ambitious pan-European launch of their brand Yondelis®. And how, without any sales infrastructure, they were meeting and beating targets faster than anyone thought possible. -
Harnessing a Speciality Salesforce
March 26, 2009
NovaQuest’s predecessor, PharmaBio Development, committed more than $400 million in milestone payments and sales force services to fund the launch of Cymbalta and support commercialization efforts for five years. A dedicated service company created by PharmaBio Development is providing more than 500 Innovex sales representatives to supplement the extensive Lilly primary care and specialty sales forces. -
Training Multiple Levels of Field Staff
March 24, 2009
Learn about the customer situation, critical issues, the Innovex solution and results. -
Multi-Country Market Development
March 20, 2009
When PharmaMar achieved EU authorization for the commercialization of Yondelis® in the treatment of advanced soft tissue sarcoma, the company faced a massive logistical challenge.
Page 1 of 1 (6 items)